- Home
- RVNC vs YSG Comparison
RVNC vs YSG Comparison
Compare RVNC & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- YSG
- Stock Information
- Founded
- RVNC 1999
- YSG 2016
- Country
- RVNC United States
- YSG China
- Employees
- RVNC N/A
- YSG N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- YSG Package Goods/Cosmetics
- Sector
- RVNC Health Care
- YSG Consumer Discretionary
- Exchange
- RVNC Nasdaq
- YSG Nasdaq
- Market Cap
- RVNC 546.4M
- YSG N/A
- IPO Year
- RVNC 2014
- YSG 2020
- Fundamental
- Price
- RVNC $5.14
- YSG $3.55
- Analyst Decision
- RVNC Buy
- YSG
- Analyst Count
- RVNC 10
- YSG 0
- Target Price
- RVNC $10.86
- YSG N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- YSG 262.4K
- Earning Date
- RVNC 11-06-2024
- YSG 11-19-2024
- Dividend Yield
- RVNC N/A
- YSG N/A
- EPS Growth
- RVNC N/A
- YSG N/A
- EPS
- RVNC N/A
- YSG N/A
- Revenue
- RVNC $251,178,000.00
- YSG $462,190,479.00
- Revenue This Year
- RVNC $20.36
- YSG $2.29
- Revenue Next Year
- RVNC $31.66
- YSG $5.70
- P/E Ratio
- RVNC N/A
- YSG N/A
- Revenue Growth
- RVNC 40.23
- YSG N/A
- 52 Week Low
- RVNC $2.30
- YSG $1.99
- 52 Week High
- RVNC $9.90
- YSG $5.20
- Technical
- Relative Strength Index (RSI)
- RVNC 39.01
- YSG 61.98
- Support Level
- RVNC $5.13
- YSG $3.26
- Resistance Level
- RVNC $5.41
- YSG $3.58
- Average True Range (ATR)
- RVNC 0.18
- YSG 0.26
- MACD
- RVNC -0.01
- YSG 0.04
- Stochastic Oscillator
- RVNC 49.02
- YSG 82.61
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.